Pdf (856.12 K)
Total Page:16
File Type:pdf, Size:1020Kb
Load more
Recommended publications
-
Potential Applications of Curcumin and Curcumin Nanoparticles: from Traditional Therapeutics to Modern Nanomedicine
Nanotechnol Rev 2015; 4(2): 161–172 Review Mahendra Rai*, Raksha Pandit, Swapnil Gaikwad, Alka Yadav and Aniket Gade Potential applications of curcumin and curcumin nanoparticles: from traditional therapeutics to modern nanomedicine Abstract: Curcumin (diferuloylmethane) is one of the regions throughout the world and widely cultivated in potent, nontoxic, and major bioactive components pre- Asian countries, mostly in India and China [2, 3]. sent in turmeric. The major drawbacks of curcumin are Curcumin was isolated for the first time in 1815, while low absorption and poor bioavailability. The present its chemical structure was determined in 1973 by Rough- review highlights on the methods for the fabrication of ley and Whiting (Figure 1). The melting point of curcumin curcumin nanoparticles and their applications in treat- is 176–177°C, and it forms red to brown-colored salts when ment of cancer and wound infections. Curcumin nano- treated with alkalis [4]. Commercial curcumin possess particles possess remarkable antibacterial, antiviral, and approximately 77% diferuloylmethane, 17% demethoxy- antiprotozoan activity. Hence, curcumin nanoparticle- curcumin (Figure 2), and 6% bisdemethoxycurcumin [5] loaded nano-gel, microemulsion, and nano-cream can be (Figure 3). Curcumin is a natural compound, which is used for drug delivery. hydrophobic in nature. It consists of two polyphenolic rings, which are substituted by methoxy ether at the Keywords: antimicrobial activity; curcumin; curcumin ortho position, and tautomerization of curcumin arises nanoparticles. in a pH-dependent condition [6]; in neutral and acidic conditions, curcumin possesses a bis-keto form [1,7-bis (4-hydroxy-3-methoxyphenyl)-1,6-heptadiene-3,5-dione]. DOI 10.1515/ntrev-2015-0001 Received January 2, 2015; accepted February 4, 2015; previously pub- Curcumin functions as an antioxidant, anti-inflamma- lished online March 19, 2015 tory, and anti-atherosclerotic. -
(12) United States Patent (10) Patent No.: US 9.421,180 B2 Zielinski Et Al
USOO9421 180B2 (12) United States Patent (10) Patent No.: US 9.421,180 B2 Zielinski et al. (45) Date of Patent: Aug. 23, 2016 (54) ANTIOXIDANT COMPOSITIONS FOR 6,203,817 B1 3/2001 Cormier et al. .............. 424/464 TREATMENT OF INFLAMMATION OR 6,323,232 B1 1 1/2001 Keet al. ............ ... 514,408 6,521,668 B2 2/2003 Anderson et al. ..... 514f679 OXIDATIVE DAMAGE 6,572,882 B1 6/2003 Vercauteren et al. ........ 424/451 6,805,873 B2 10/2004 Gaudout et al. ....... ... 424/401 (71) Applicant: Perio Sciences, LLC, Dallas, TX (US) 7,041,322 B2 5/2006 Gaudout et al. .............. 424/765 7,179,841 B2 2/2007 Zielinski et al. .. ... 514,474 (72) Inventors: Jan Zielinski, Vista, CA (US); Thomas 2003/0069302 A1 4/2003 Zielinski ........ ... 514,452 Russell Moon, Dallas, TX (US); 2004/0037860 A1 2/2004 Maillon ...... ... 424/401 Edward P. Allen, Dallas, TX (US) 2004/0091589 A1 5, 2004 Roy et al. ... 426,265 s s 2004/0224004 A1 1 1/2004 Zielinski ..... ... 424/442 2005/0032882 A1 2/2005 Chen ............................. 514,456 (73) Assignee: Perio Sciences, LLC, Dallas, TX (US) 2005, 0137205 A1 6, 2005 Van Breen ..... 514,252.12 2005. O154054 A1 7/2005 Zielinski et al. ............. 514,474 (*) Notice: Subject to any disclaimer, the term of this 2005/0271692 Al 12/2005 Gervasio-Nugent patent is extended or adjusted under 35 et al. ............................. 424/401 2006/0173065 A1 8/2006 BeZwada ...................... 514,419 U.S.C. 154(b) by 19 days. 2006/O193790 A1 8/2006 Doyle et al. -
Antioxidant Efficacy of Curcuminoids from Turmeric ( Curcuma Longa L
Downloaded from British Journal of Nutrition (2009), 102, 1629–1634 doi:10.1017/S0007114509990869 q The Authors 2009 https://www.cambridge.org/core Antioxidant efficacy of curcuminoids from turmeric (Curcuma longa L.) powder in broiler chickens fed diets containing aflatoxin B1 Nisarani K. S. Gowda1*, David R. Ledoux2, Goerge E. Rottinghaus2, Alex J. Bermudez2 and Yin C. Chen2 . IP address: 1National Institute of Animal Nutrition and Physiology, Bangalore 560030, India 2Fusarium/Poultry Research Laboratory, University of Missouri, Columbia, MO 65211, USA 170.106.35.76 (Received 6 November 2008 – Revised 21 May 2009 – Accepted 28 May 2009 – First published online 17 August 2009) , on A 3-week-feeding study (1–21 d post-hatch) was conducted to evaluate the efficacy of total curcuminoids (TCMN), as an antioxidant, to amelio- 29 Sep 2021 at 12:56:31 rate the adverse effects of aflatoxin B1 (AFB1) in broiler chickens. Turmeric powder (Curcuma longa L.) that contained 2·55 % TCMN was used as a source of TCMN. Six cage replicates of five chicks each were assigned to each of six dietary treatments, which included: basal diet; basal diet supplemented with 444 mg/kg TCMN; basal diet supplemented with 1·0 mg/kg AFB1; basal diet supplemented with 74 mg/kg TCMN and 1·0 mg/kg AFB1; basal diet supplemented with 222 mg/kg TCMN and 1·0 mg/kg AFB1; basal diet supplemented with 444 mg/kg TCMN and 1·0 mg/kg AFB1. The addition of 74 and 222 mg/kg TCMN to the AFB1 diet significantly (P,0·05) improved weight gain and feed efficiency. -
USP Statement on Validation of DNA Test Methods for Regulating the Quality of Herbal Supplements
USP Statement on Validation of DNA Test Methods for Regulating the Quality of Herbal Supplements U.S. PHARMACOPEIAL CONVENTION The United States Pharmacopeial Convention Urges Scientific Validation of DNA Test Methods for Regulating the Quality of Herbal Supplements (Rockville, MD – April 16, 2015) – In response to an agreement announced between the New York State Attorney General (NYAG) and GNC Holdings, Inc. (GNC) the United States Pharmacopeial Convention (USP), an independent, science based, standards setting organization and publishers of the United States Pharmacopeia-National Formulary (USP-NF), an official compendia of quality standards for dietary supplements sold in the U.S., issued the following statement: Statement by Gabriel Giancaspro, PhD – Vice President –Foods, Dietary Supplement and Herbal Medicines United States Pharmacopeial Convention (USP) “As a science-based standards-setting organization, the United States Pharmacopeial Convention (USP) has a keen interest in adopting emerging technologies to ensure the test methods and quality standards included in the United States Pharmacopeia-National Formulary (USP-NF) are current and reflect the state of the industry. DNA testing including DNA Barcoding, is just one example of a technology that has been recently added to the USP-NF. As of December 2014, DNA-based identification methods are included in the official USP chapter <563> Identification of Articles of Botanical Origin. However, this method is not yet referenced in a USP-NF monograph (quality standard) for a specific ingredient or product. That is because USP quality standards are specific for each ingredient, product and dosage form and the standards we develop include only those test methods that have been scientifically validated and shown to be fit for purpose. -
Impact of High Pressure on the Infusion of Curcuminoids in Pineapple Slices
George JM and Rastogi NK, J Food Sci Nutr 2017, 3: 027 DOI: 10.24966/FSN-1076/100027 HSOA Journal of Food Science and Nutrition Research Article by many research workers. However, it is relatively a slow and time Impact of High Pressure on the consuming process. Hence, a few techniques have been acknowledged in order to enhance the rate of osmotically induced mass transfer that Infusion of Curcuminoids in include partial vacuum [10,11], pulsed vacuum [12], high pressure [13-15], high intensity pulsed electric field [16,17], ohmic heating Pineapple Slices [18,19] or ultrasound [20-23]. Application of high pressure treatment Jincy M George1,2 and Navin K Rastogi1,2* accelerated the diffusion of bioactive components into the solid food 1ACSIR, Central Food Technological Research Institute, Mysore, India due to cell membranes permeabilisation resulting in decline in the re- sistance to infusion [24,25]. The application of high pressure pretreat- 2 Department of Food Engineering, Central Food Technological Research ment was described to increase the water and solute diffusion during Institute, Mysore, India osmotic dehydration of pineapples, potato, glutinous rice and turkey breast [26-29]. Sila et al., [30] demonstrated that combined effect of high pressure treatment and CaCl2 treatment improved the texture of carrots during thermal processing. High pressure-assisted infusion of pectin methyl esterase and calcium chloride in strawberry was shown to improve the firmness [13,31]. Mahadevan et al., [32] indicated that high pressure pretreatment increased infusion of quercetin by 3 times into cranberries as compared to untreated ones. Incorporation of synthetic antioxidants like Butylated Hydroxy- anisole (BHA) and Butylated Hydroxy Toluene (BHT) are restricted Abstract by legislative laws and regulations due to carcinogenic effects [33]. -
Curcumin and Resveratrol in the Management of Cognitive Disorders: What Is the Clinical Evidence?
Review Curcumin and Resveratrol in the Management of Cognitive Disorders: What is the Clinical Evidence? Gabriela Mazzanti * and Silvia Di Giacomo Department of Physiology and Pharmacology, Sapienza - University of Rome, P.le Aldo Moro 5, 00185 Rome, Italy. * Correspondence: [email protected]; Tel.: +39-064-991-2903 Academic Editor: Luigia Trabace Received: 26 July 2016; Accepted: 12 September 2016; Published: 17 September 2016 Abstract: A growing body of in vitro and in vivo evidences shows a possible role of polyphenols in counteracting neurodegeneration: curcumin and resveratrol are attractive substances in this regard. In fact, epidemiological studies highlight a neuroprotective effect of turmeric (rhizome of Curcuma longa L.), the main source of curcumin. Moreover, the consumption of red wine, the main source of resveratrol, has been related to a lower risk of developing dementia. In this review, we analyzed the published clinical trials investigating curcumin and resveratrol in the prevention or treatment of cognitive disorders. The ongoing studies were also described, in order to give an overview of the current search on this topic. The results of published trials (five for curcumin, six for resveratrol) are disappointing and do not allow to draw conclusions about the therapeutic or neuroprotective potential of curcumin and resveratrol. These compounds, being capable of interfering with several processes implicated in the early stages of dementia, could be useful in preventing or in slowing down the pathology. To this aim, an early diagnosis using peripheral biomarkers becomes necessary. Furthermore, the potential preventive activity of curcumin and resveratrol should be evaluated in long-term exposure clinical trials, using preparations with high bioavailability and that are well standardized. -
Review Article Polyphenols As Modulator of Oxidative Stress in Cancer Disease: New Therapeutic Strategies
View metadata, citation and similar papers at core.ac.uk brought to you by CORE provided by Crossref Hindawi Publishing Corporation Oxidative Medicine and Cellular Longevity Volume 2016, Article ID 6475624, 17 pages http://dx.doi.org/10.1155/2016/6475624 Review Article Polyphenols as Modulator of Oxidative Stress in Cancer Disease: New Therapeutic Strategies Anna Maria Mileo and Stefania Miccadei Regina Elena National Cancer Institute, 00144 Rome, Italy Correspondence should be addressed to Stefania Miccadei; [email protected] Received 22 May 2015; Accepted 21 July 2015 Academic Editor: Amit Tyagi Copyright © 2016 A. M. Mileo and S. Miccadei. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. Cancer onset and progression have been linked to oxidative stress by increasing DNA mutations or inducing DNA damage, genome instability, and cell proliferation and therefore antioxidant agents could interfere with carcinogenesis. It is well known that conventional radio-/chemotherapies influence tumour outcome through ROS modulation. Since these antitumour treatments have important side effects, the challenge is to develop new anticancer therapeutic strategies more effective and less toxic for patients. To this purpose, many natural polyphenols have emerged as very promising anticancer bioactive compounds. Beside their well-known antioxidant activities, several polyphenols target epigenetic processes involved in cancer development through the modulation of oxidative stress. An alternative strategy to the cytotoxic treatment is an approach leading to cytostasis through the induction of therapy-induced senescence. Many anticancer polyphenols cause cellular growth arrest through the induction of a ROS-dependent premature senescence and are considered promising antitumour therapeutic tools. -
Curcumin in Autoimmune and Rheumatic Diseases
nutrients Review Curcumin in Autoimmune and Rheumatic Diseases Melissa Yang, Umair Akbar and Chandra Mohan * Department of Biomedical Engineering, University of Houston, 3517 Cullen Blvd, Room 2004, Houston, TX 77204, USA; [email protected] (M.Y.); [email protected] (U.A.) * Correspondence: [email protected]; Tel.: 713-743-3709 Received: 29 March 2019; Accepted: 24 April 2019; Published: 2 May 2019 Abstract: Over recent decades, many clinical trials on curcumin supplementation have been conducted on various autoimmune diseases including osteoarthritis, type 2 diabetes, and ulcerative colitis patients. This review attempts to summarize the highlights from these clinical trials. The efficacy of curcumin either alone or in conjunction with existing treatment was evaluated. Sixteen clinical trials have been conducted in osteoarthritis, 14 of which yielded significant improvements in multiple disease parameters. Eight trials have been conducted in type 2 diabetes, all yielding significant improvement in clinical or laboratory outcomes. Three trials were in ulcerative colitis, two of which yielded significant improvement in at least one clinical outcome. Additionally, two clinical trials on rheumatoid arthritis, one clinical trial on lupus nephritis, and two clinical trials on multiple sclerosis resulted in inconclusive results. Longer duration, larger cohort size, and multiple dosage arm trials are warranted to establish the long term benefits of curcumin supplementation. Multiple mechanisms of action of curcumin on these diseases have been researched, including the modulation of the eicosanoid pathway towards a more anti-inflammatory pathway, and the modulation of serum lipid levels towards a favorable profile. Overall, curcumin supplementation emerges as an effective therapeutic agent with minimal-to-no side effects, which can be added in conjunction to current standard of care. -
Genome Sequencing of Turmeric Provides Evolutionary Insights Into Its Medicinal Properties
bioRxiv preprint doi: https://doi.org/10.1101/2020.09.07.286245; this version posted September 9, 2020. The copyright holder for this preprint (which was not certified by peer review) is the author/funder. All rights reserved. No reuse allowed without permission. 1 Title: Genome sequencing of turmeric provides evolutionary insights into its medicinal properties 2 Authors: Abhisek Chakraborty, Shruti Mahajan, Shubham K. Jaiswal, Vineet K. Sharma* 3 4 Affiliation: 5 MetaBioSys Group, Department of Biological Sciences, Indian Institute of Science Education and 6 Research Bhopal 7 8 *Corresponding Author email: 9 Vineet K. Sharma - [email protected] 10 11 E-mail addresses of authors: 12 Abhisek Chakraborty - [email protected], Shruti Mahajan - [email protected], Shubham K. 13 Jaiswal - [email protected], Vineet K. Sharma - [email protected] bioRxiv preprint doi: https://doi.org/10.1101/2020.09.07.286245; this version posted September 9, 2020. The copyright holder for this preprint (which was not certified by peer review) is the author/funder. All rights reserved. No reuse allowed without permission. 14 ABSTRACT 15 Curcuma longa, or turmeric, is traditionally known for its immense medicinal properties and has 16 diverse therapeutic applications. However, the absence of a reference genome sequence is a limiting 17 factor in understanding the genomic basis of the origin of its medicinal properties. In this study, we 18 present the draft genome sequence of Curcuma longa, the first species sequenced from 19 Zingiberaceae plant family, constructed using 10x Genomics linked reads. For comprehensive gene 20 set prediction and for insights into its gene expression, the transcriptome sequencing of leaf tissue 21 was also performed. -
USP Reference Standards Catalog
Last Updated On: November 7, 2020 USP Reference Standards Catalog Catalog Status RS Name Current Previous Lot CAS # NDC # Unit Co. Of Material UN # Net Unit Commodity Special Pkg. USMCA KORUS Base Base # Lot (VUD) Price Origin Origin Weight Of Codes Restriction Type Eligible Eligible Control Control Measur (HS Codes)* Drug Drug % e 1000408 Active Abacavir Sulfate (200 R108M0 R028L0 (30- 188062- N/A $245.00 GB Chemical 200 mg 2933595960 No No mg) JUN-2020) 50-2 Synthesis 1000419 Active Abacavir Sulfate F0G248 188062- N/A $760.00 IN Chemical 20 mg 2933595960 No No Racemic (20 mg) (4- 50-2 Synthesis [2-amino-6- (cyclopropylamino)- 9H-purin-9yl]-2- cyclopentene-1- methanol sulfate (2:1)) 1000420 Active Abacavir Related F1L311 F0H284 (31- 906626- N/A $877.00 IN Chemical 20 mg 2933599550 No No Compound A (20 mg) OCT-2013) 51-5 Synthesis ([4-(2,6-diamino-9H- purin-9-yl)cyclopent- 2-enyl]methanol) 1000437 Active Abacavir Related F0M143 N/A N/A $877.00 IN Chemical 20 mg 2933599550 No No Compound D (20 mg) Synthesis (N6-Cyclopropyl-9- {(1R,4S)-4-[(2,5- diamino-6- chlorpyrimidin-4- yloxy)methyl] cyclopent-2-enyl}-9H- purine-2,6-diamine) 1000441 Active Abacavir Related F1L318 F0H283 (31- N/A N/A $877.00 IN Chemical 20 mg 2933599550 No No Compound B (20 mg) OCT-2013) Synthesis ([4-(2,5-diamino-6- chloropyrimidin-4- ylamino)cyclopent-2- enyl]methanol) 1000452 Active Abacavir Related F1L322 F0H285 (30- 172015- N/A $960.00 IN Chemical 20 mg 2933599550 No No Compound C (20 mg) SEP-2013) 79-1 Synthesis ([(1S,4R)-4-(2-amino- 6-chloro-9H-purin-9- yl)cyclopent-2- -
Dietary Supplements Compendium Volume 1
2015 Dietary Supplements Compendium DSC Volume 1 General Notices and Requirements USP–NF General Chapters USP–NF Dietary Supplement Monographs USP–NF Excipient Monographs FCC General Provisions FCC Monographs FCC Identity Standards FCC Appendices Reagents, Indicators, and Solutions Reference Tables DSC217M_DSCVol1_Title_2015-01_V3.indd 1 2/2/15 12:18 PM 2 Notice and Warning Concerning U.S. Patent or Trademark Rights The inclusion in the USP Dietary Supplements Compendium of a monograph on any dietary supplement in respect to which patent or trademark rights may exist shall not be deemed, and is not intended as, a grant of, or authority to exercise, any right or privilege protected by such patent or trademark. All such rights and privileges are vested in the patent or trademark owner, and no other person may exercise the same without express permission, authority, or license secured from such patent or trademark owner. Concerning Use of the USP Dietary Supplements Compendium Attention is called to the fact that USP Dietary Supplements Compendium text is fully copyrighted. Authors and others wishing to use portions of the text should request permission to do so from the Legal Department of the United States Pharmacopeial Convention. Copyright © 2015 The United States Pharmacopeial Convention ISBN: 978-1-936424-41-2 12601 Twinbrook Parkway, Rockville, MD 20852 All rights reserved. DSC Contents iii Contents USP Dietary Supplements Compendium Volume 1 Volume 2 Members . v. Preface . v Mission and Preface . 1 Dietary Supplements Admission Evaluations . 1. General Notices and Requirements . 9 USP Dietary Supplement Verification Program . .205 USP–NF General Chapters . 25 Dietary Supplements Regulatory USP–NF Dietary Supplement Monographs . -
Bioactivity of Curcumin on the Cytochrome P450 Enzymes of the Steroidogenic Pathway
International Journal of Molecular Sciences Article Bioactivity of Curcumin on the Cytochrome P450 Enzymes of the Steroidogenic Pathway Patricia Rodríguez Castaño 1,2, Shaheena Parween 1,2 and Amit V Pandey 1,2,* 1 Pediatric Endocrinology, Diabetology, and Metabolism, University Children’s Hospital Bern, 3010 Bern, Switzerland; [email protected] (P.R.C.); [email protected] (S.P.) 2 Department of Biomedical Research, University of Bern, 3010 Bern, Switzerland * Correspondence: [email protected]; Tel.: +41-31-632-9637 Received: 5 September 2019; Accepted: 16 September 2019; Published: 17 September 2019 Abstract: Turmeric, a popular ingredient in the cuisine of many Asian countries, comes from the roots of the Curcuma longa and is known for its use in Chinese and Ayurvedic medicine. Turmeric is rich in curcuminoids, including curcumin, demethoxycurcumin, and bisdemethoxycurcumin. Curcuminoids have potent wound healing, anti-inflammatory, and anti-carcinogenic activities. While curcuminoids have been studied for many years, not much is known about their effects on steroid metabolism. Since many anti-cancer drugs target enzymes from the steroidogenic pathway, we tested the effect of curcuminoids on cytochrome P450 CYP17A1, CYP21A2, and CYP19A1 enzyme activities. When using 10 µg/mL of curcuminoids, both the 17α-hydroxylase as well as 17,20 lyase activities of CYP17A1 were reduced significantly. On the other hand, only a mild reduction in CYP21A2 activity was observed. Furthermore, CYP19A1 activity was also reduced up to ~20% of control when using 1–100 µg/mL of curcuminoids in a dose-dependent manner. Molecular docking studies confirmed that curcumin could dock onto the active sites of CYP17A1, CYP19A1, as well as CYP21A2.